Oncternal Therapeutics Inc (ONCT)
$1.70
0.05 (3.03%)
ONCT Stock Quote Delayed 30 Minutes
ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q2 2024
ONCT stock results show that Oncternal Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
99.81M
PE Ratio
-0.09
EPS
-18.8
Volume (Avg. Vol.)
18,204
Day's Range
$1.61 - $1.77
52-Week Range
$1.32 - $13.14
Dividend & Yield
N/A (N/A)
